Bausch Health Companies (BHC) - Quarterly EPS earnings growth

Corporate company logo of Bausch Health Corp (BHC)

Bausch Health Companies (BHC) high debt levels create risks for its diversified ecosystem in dermatology and gastroenterology. The quarterly EPS trend captures these fluctuations, with the current metric standing at 140.10. Partnerships with ophthalmology centers and strict FDA standards restore stability, which, combined with patents, limit the market entry of new players.

bauschhealth.com (BHC) Year-over-year earnings per share growth for the last 12 months: for the period 07/04/2022 - 11/15/2026

Financial and market metric breakdowns for Bausch Health Companies (BHC)

- share price and expert price forecast:
Stock Price Bausch Health Companies|BHC - Broker Consensus Forecast
- market capitalization indicators:
Market Capitalization Bausch Health Companies|BHC - Company Buyout Price
- balance sheet net asset value indicators:
Net Assets per Single Share Bausch Health|BHC - Accounting Capitalization|Market Capitalization to Book Value Ratio bauschhealth.com|BHC - Company Balance Sheet Assets
- debt level and financial liquidity data:
Total Debt to Capital Bausch Health Companies|BHC - Long-Term Debt to Equity|Short-Term Debt to Capital bauschhealth.com|BHC - Company Aggregate Debts|Debt to Book Value Bausch Health Corp|BHC - Company Long-Term Debts|Company Short-Term Debt Bausch Health|Quick Ratio bauschhealth.com
- earnings and market multiples details:
BHC - Net Income|Projected Future Earnings Bausch Health Companies|BHC - Company Value to Net Income|Projected Price to Earnings Bausch Health Companies|BHC - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Bausch Health Companies Inc.|BHC - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Bausch Health|BHC - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth bauschhealth.com|BHC - Earnings growth in current year|Net earnings per share growth forecast for next year Bausch Health Companies
- company sales and revenue statistics:
BHC - Company Revenue|Company Future Sales Volume Bausch Health|BHC - Market Cap to Sales Volume|Forward P/S Multiple Bausch Health Companies Inc.|BHC - Revenue Dynamics YoY (Last Twelve Months)
Initial company analysis:Bausch Health Companies Inc., BHC
Flagship merchandise of Bausch Health Corp

The optimization of the niche drug portfolio at Bausch Health Companies (BHC) directly impacts profit generation efficiency. This indicator measures the quarterly rate of change in earnings per share, reflecting market expectations. Investors utilize this metric for the early detection of a reversal in the yield trend. The current value of 140.10 characterizes the real-time capital dynamics. Analyzing the speed of quarterly EPS growth allows for the timely identification of hidden business imbalances.

Competitor analysis

LLY: Quarterly EPS earnings growth|ABBV (Abbvie) - Year-over-year earnings per share growth for the last twelve months|AZN (astrazeneca.com) - Quarterly EPS earnings growth|novartis.com (NVS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Merck Sharp & Dohme (MRK)|Novo Nordisk - Year-over-year earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Amgen Inc. AMGN|Net earnings per share growth for the trailing year Pfizer Corp|SNY - Year-over-year earnings per share growth for the last twelve months|BMY: Year-over-year earnings per share growth for the last twelve months|GSK plc (GSK) - Year-over-year earnings per share growth for the last twelve months|Takeda Pharmaceutical Company (TAK) - Quarterly EPS earnings growth|TEVA (tevapharm.com) - Quarterly EPS earnings growth|Dr. Reddy's Laboratories (RDY) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth VTRS|Year-over-year net earnings per share change for the last twelve months Roivant Sciences|Zai Lab - Year-over-year net earnings per share growth for the last 12 months|COSM - Year-over-year net earnings per share growth for the last 12 months